{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:37:38Z","timestamp":1787060258094,"version":"build-2736575974"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>The application of randomized controlled trials (RCTs) outcomes of botulinum toxin type A (BoNT-A) to actual patient care faces a significant hurdle due to research waste (RW). This includes the results of RCTs that have not been published even 4 years after completion and those with insufficiently reported outcomes and design flaws. The prevalence of RW within BoNT-A-associated RCTs remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the extent of RW (non-publication, insufficient reporting, and design flaws) in BoNT-A RCTs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The authors searched the ClinicalTrials using \u2018botulinum toxin type A\u2019 as the keyword. They verified the publication status through PubMed and Scopus searches. The adequacy of reporting was assessed using the Consolidated Standards of Reporting Trials checklist, while design limitations were evaluated based on the risk of bias and systematic reviews.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Two hundred twenty-eight RCTs met the inclusion criteria for characteristics presentation. The RW analysis omitted 53 RCTs completed after June 2020, which remained unpublished. Of the 175 RCTs assessed, 98 were published, 71 demonstrated adequate reporting, and 25 had design limitations. Altogether, 118 RCTs (67.4%) exhibited at least 1 trait of RW. Multicenter designs and registrations post-2014 were independent protective factors against RW.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Within the 175 RCTs included in RW analysis, 67.4% of the studies presented some form of RW. The varied characteristics of the identified RW indicators offer essential insights for more rational planning of future BoNT-A RCTs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/dss.0000000000004552","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T08:00:42Z","timestamp":1737532842000},"page":"e1-e4","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of Research Waste in Phase III\/IV Randomized Controlled Trials of Botulinum Toxin Type A"],"prefix":"10.1097","volume":"51","author":[{"given":"Hongrui","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Lin","sequence":"additional","affiliation":[{"name":"All authors are affiliated with the Department of Plastic & Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Ninth People's Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"R1-20250529","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins16070309","article-title":"Clinical conditions targeted by OnabotulinumtoxinA in different ways in medicine","volume":"16","author":"Onan","year":"2024","journal-title":"Toxins (Basel)"},{"key":"R2-20250529","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/bjs.11266","article-title":"Research waste in surgical randomized controlled trials","volume":"106","author":"Chapman","year":"2019","journal-title":"Br J Surg"},{"key":"R3-20250529","doi-asserted-by":"crossref","first-page":"e2124760","DOI":"10.1001\/jamanetworkopen.2021.24760","article-title":"Characteristics and research waste among randomized clinical trials in gastric cancer","volume":"4","author":"Lu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R4-20250529","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(11)61772-8","article-title":"Need to realign patient-oriented and commercial and academic research","volume":"378","author":"Liberati","year":"2011","journal-title":"Lancet"},{"key":"R5-20250529","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(13)62229-1","article-title":"How to increase value and reduce waste when research priorities are set","volume":"383","author":"Chalmers","year":"2014","journal-title":"Lancet"},{"key":"R6-20250529","doi-asserted-by":"crossref","first-page":"106165","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"Strocss 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"R7-20250529","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","article-title":"An analysis of contemporary oncology randomized clinical trials from low\/middle-income vs high-income countries","volume":"7","author":"Wells","year":"2021","journal-title":"JAMA Oncol"},{"key":"R8-20250529","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R9-20250529","doi-asserted-by":"crossref","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","article-title":"Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration","volume":"148","author":"Boutron","year":"2008","journal-title":"Ann Intern Med"},{"key":"R10-20250529","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R11-20250529","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1055\/a-2324-6262","article-title":"Sessile serrated lesion prevalence and factors associated with their detection: a post-hoc analysis of a multinational randomized controlled trial from Asia","volume":"56","author":"Tan","year":"2024","journal-title":"Endoscopy"},{"key":"R12-20250529","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jama.290.4.495","article-title":"Factors associated with failure to publish large randomized trials presented at an oncology meeting","volume":"290","author":"Krzyzanowska","year":"2003","journal-title":"JAMA"},{"key":"R13-20250529","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12916-023-03113-0","article-title":"A 10-year update to the principles for clinical trial data sharing by pharmaceutical companies: perspectives based on a decade of literature and policies","volume":"21","author":"Modi","year":"2023","journal-title":"BMC Med"},{"key":"R14-20250529","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jclinepi.2022.09.012","article-title":"The role of scoping reviews in reducing research waste","volume":"152","author":"Khalil","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"R15-20250529","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.1038\/s41467-022-33056-8","article-title":"Transparent peer review for all","volume":"13","year":"2022","journal-title":"Nat Commun"},{"key":"R16-20250529","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1038\/ncomms10277","article-title":"Transparent peer review at nature communications","volume":"6","year":"2015","journal-title":"Nat Commun"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T13:00:13Z","timestamp":1748523613000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004552","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]}}}